Tranexamic Acid (Apotex Corp.)
Welcome to the PulseAid listing for the Tranexamic Acid drug offered from Apotex Corp.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | Tranexamic Acid |
SUBSTANCE NAME: | TRANEXAMIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-01-27 |
END MARKETING DATE: | 0000-00-00 |
Tranexamic Acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Tranexamic Acid from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 650(1-Jan) |
START MARKETING DATE: | 2014-01-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-3638_4e51f884-e586-b989-728a-6c67eeab53e4 |
PRODUCT NDC: | 60505-3638 |
APPLICATION NUMBER: | ANDA202286 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers: